Antisense and RNAi Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (RNA Interference, Antisense RNA); Route of Administration (Pulmonary Delivery, Intravenous Injections, Intra-Dermal, Intraperitoneal, Topical, Others); Application (Infectious Diseases, Cardiovascular Diseases, Cancer, Neurological Disorders, Others.) and Geography

Report Code: TIPRE00023784 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Antisense and RNAi therapeutics are the new class of drugs used to treat various diseases. They exert their effect by silencing a portion of RNA via short interfering RNAs (siRNAs) or microRNAs (miRNAs) involved in causing the disease or inducing the degradation of targeted mRNA by RNase enzyme and reducing undesirable protein translation. They treat diseases that target nucleic acid and affect the cell growth cycle.

MARKET SCOPE

The "Global Antisense & RNAi Therapeutics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antisense & RNAi therapeutics market with detailed market segmentation by type, route of administration, application, and geography. The report provides key statistics on the market status of the leading antisense & RNAi therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

    - Based on type, the global antisense & RNAi therapeutics market is segmented into RNA interference and antisense RNA.
    - On the basis of route of administration, the market is bifurcated into pulmonary delivery, intravenous injections, intra-dermal, intraperitoneal, topical and others.
    - Based on application, the market is segmented into infectious diseases, cardiovascular diseases, cancer, neurological disorders and others.

MARKET DYNAMICS
Drivers:

    - The increasing prevalence of coronary artery diseases, neurodegenerative disorders, and infectious diseases drive the growth of the antisense & RNAi therapeutics market.
    - Growing advancement in the treatment options to target specificity and selectivity fuel market growth.
    - The rapid adoption of novel drug delivery and approval and launch of RNA therapeutics boost market growth.
    - Growing funding for research and development activities propel market growth.

Restraints:

    - High cost of RNA interference-based drugs.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antisense & RNAi therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the antisense & RNAi therapeutics market in these regions.

IMPACT OF COVID-19 ON ANTISENSE & RNAI THERAPEUTICS MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. During the pandemic outbreak, the market's growth was impacted due to business shutdown, worldwide lockdown, and supply and trade disruptions. There was an increased demand to develop a vaccine for prevention from the Covid-19 virus resulting in R&D activities focus shifting towards the development of the vaccine. This affected the growth of other sectors. However, the market is likely to witness growth due to companies resuming their operations and adapting themselves to the new normal.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the antisense & RNAi therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from antisense & RNAi therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for antisense & RNAi therapeutics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the antisense & RNAi therapeutics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

    - Alnylam Pharmaceuticals
    - Benitec Biopharma Ltd.
    - Quark Pharmaceuticals
    - Ionis Pharmaceuticals
    - Astellas Pharma Inc
    - Marina Biosciences
    - Sanofi S
    - Dicerna Pharmaceuticals
    - Tekmira Pharmaceuticals
    - Merck
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antisense And RNAi Therapeutics Market - By Type
1.3.2 Antisense And RNAi Therapeutics Market - By Route of Administration
1.3.3 Antisense And RNAi Therapeutics Market - By Application
1.3.4 Antisense And RNAi Therapeutics Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTISENSE AND RNAI THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTISENSE AND RNAI THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTISENSE AND RNAI THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTISENSE AND RNAI THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ANTISENSE AND RNAI THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. ANTISENSE AND RNAI THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. RNA INTERFERENCE
7.3.1. Overview
7.3.2. RNA Interference Market Forecast and Analysis
7.4. ANTISENSE RNA
7.4.1. Overview
7.4.2. Antisense RNA Market Forecast and Analysis
8. ANTISENSE AND RNAI THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. PULMONARY DELIVERY
8.3.1. Overview
8.3.2. Pulmonary Delivery Market Forecast and Analysis
8.4. INTRAVENOUS INJECTIONS
8.4.1. Overview
8.4.2. Intravenous Injections Market Forecast and Analysis
8.5. INTRA-DERMAL
8.5.1. Overview
8.5.2. Intra-Dermal Market Forecast and Analysis
8.6. INTRAPERITONEAL
8.6.1. Overview
8.6.2. Intraperitoneal Market Forecast and Analysis
8.7. TOPICAL
8.7.1. Overview
8.7.2. Topical Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. ANTISENSE AND RNAI THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. INFECTIOUS DISEASES
9.3.1. Overview
9.3.2. Infectious Diseases Market Forecast and Analysis
9.4. CARDIOVASCULAR DISEASES
9.4.1. Overview
9.4.2. Cardiovascular Diseases Market Forecast and Analysis
9.5. CANCER
9.5.1. Overview
9.5.2. Cancer Market Forecast and Analysis
9.6. NEUROLOGICAL DISORDERS
9.6.1. Overview
9.6.2. Neurological Disorders Market Forecast and Analysis
9.7. OTHERS.
9.7.1. Overview
9.7.2. Others. Market Forecast and Analysis

10. ANTISENSE AND RNAI THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Antisense And RNAi Therapeutics Market Overview
10.1.2 North America Antisense And RNAi Therapeutics Market Forecasts and Analysis
10.1.3 North America Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Type
10.1.4 North America Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Application
10.1.6 North America Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 Canada Antisense And RNAi Therapeutics Market
10.1.6.1.1 Canada Antisense And RNAi Therapeutics Market by Type
10.1.6.1.2 Canada Antisense And RNAi Therapeutics Market by Route of Administration
10.1.6.1.3 Canada Antisense And RNAi Therapeutics Market by Application
10.1.6.2 Mexico Antisense And RNAi Therapeutics Market
10.1.6.2.1 Mexico Antisense And RNAi Therapeutics Market by Type
10.1.6.2.2 Mexico Antisense And RNAi Therapeutics Market by Route of Administration
10.1.6.2.3 Mexico Antisense And RNAi Therapeutics Market by Application
10.1.6.3 US Antisense And RNAi Therapeutics Market
10.1.6.3.1 US Antisense And RNAi Therapeutics Market by Type
10.1.6.3.2 US Antisense And RNAi Therapeutics Market by Route of Administration
10.1.6.3.3 US Antisense And RNAi Therapeutics Market by Application
10.2. EUROPE
10.2.1 Europe Antisense And RNAi Therapeutics Market Overview
10.2.2 Europe Antisense And RNAi Therapeutics Market Forecasts and Analysis
10.2.3 Europe Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Type
10.2.4 Europe Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Application
10.2.6 Europe Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Antisense And RNAi Therapeutics Market
10.2.6.1.1 Germany Antisense And RNAi Therapeutics Market by Type
10.2.6.1.2 Germany Antisense And RNAi Therapeutics Market by Route of Administration
10.2.6.1.3 Germany Antisense And RNAi Therapeutics Market by Application
10.2.6.2 France Antisense And RNAi Therapeutics Market
10.2.6.2.1 France Antisense And RNAi Therapeutics Market by Type
10.2.6.2.2 France Antisense And RNAi Therapeutics Market by Route of Administration
10.2.6.2.3 France Antisense And RNAi Therapeutics Market by Application
10.2.6.3 Italy Antisense And RNAi Therapeutics Market
10.2.6.3.1 Italy Antisense And RNAi Therapeutics Market by Type
10.2.6.3.2 Italy Antisense And RNAi Therapeutics Market by Route of Administration
10.2.6.3.3 Italy Antisense And RNAi Therapeutics Market by Application
10.2.6.4 Spain Antisense And RNAi Therapeutics Market
10.2.6.4.1 Spain Antisense And RNAi Therapeutics Market by Type
10.2.6.4.2 Spain Antisense And RNAi Therapeutics Market by Route of Administration
10.2.6.4.3 Spain Antisense And RNAi Therapeutics Market by Application
10.2.6.5 United Kingdom Antisense And RNAi Therapeutics Market
10.2.6.5.1 United Kingdom Antisense And RNAi Therapeutics Market by Type
10.2.6.5.2 United Kingdom Antisense And RNAi Therapeutics Market by Route of Administration
10.2.6.5.3 United Kingdom Antisense And RNAi Therapeutics Market by Application
10.2.6.6 Rest of Europe Antisense And RNAi Therapeutics Market
10.2.6.6.1 Rest of Europe Antisense And RNAi Therapeutics Market by Type
10.2.6.6.2 Rest of Europe Antisense And RNAi Therapeutics Market by Route of Administration
10.2.6.6.3 Rest of Europe Antisense And RNAi Therapeutics Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Antisense And RNAi Therapeutics Market Overview
10.3.2 Asia-Pacific Antisense And RNAi Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Antisense And RNAi Therapeutics Market
10.3.6.1.1 Australia Antisense And RNAi Therapeutics Market by Type
10.3.6.1.2 Australia Antisense And RNAi Therapeutics Market by Route of Administration
10.3.6.1.3 Australia Antisense And RNAi Therapeutics Market by Application
10.3.6.2 China Antisense And RNAi Therapeutics Market
10.3.6.2.1 China Antisense And RNAi Therapeutics Market by Type
10.3.6.2.2 China Antisense And RNAi Therapeutics Market by Route of Administration
10.3.6.2.3 China Antisense And RNAi Therapeutics Market by Application
10.3.6.3 India Antisense And RNAi Therapeutics Market
10.3.6.3.1 India Antisense And RNAi Therapeutics Market by Type
10.3.6.3.2 India Antisense And RNAi Therapeutics Market by Route of Administration
10.3.6.3.3 India Antisense And RNAi Therapeutics Market by Application
10.3.6.4 Japan Antisense And RNAi Therapeutics Market
10.3.6.4.1 Japan Antisense And RNAi Therapeutics Market by Type
10.3.6.4.2 Japan Antisense And RNAi Therapeutics Market by Route of Administration
10.3.6.4.3 Japan Antisense And RNAi Therapeutics Market by Application
10.3.6.5 South Korea Antisense And RNAi Therapeutics Market
10.3.6.5.1 South Korea Antisense And RNAi Therapeutics Market by Type
10.3.6.5.2 South Korea Antisense And RNAi Therapeutics Market by Route of Administration
10.3.6.5.3 South Korea Antisense And RNAi Therapeutics Market by Application
10.3.6.6 Rest of Asia-Pacific Antisense And RNAi Therapeutics Market
10.3.6.6.1 Rest of Asia-Pacific Antisense And RNAi Therapeutics Market by Type
10.3.6.6.2 Rest of Asia-Pacific Antisense And RNAi Therapeutics Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Antisense And RNAi Therapeutics Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Antisense And RNAi Therapeutics Market Overview
10.4.2 Middle East and Africa Antisense And RNAi Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Antisense And RNAi Therapeutics Market
10.4.6.1.1 South Africa Antisense And RNAi Therapeutics Market by Type
10.4.6.1.2 South Africa Antisense And RNAi Therapeutics Market by Route of Administration
10.4.6.1.3 South Africa Antisense And RNAi Therapeutics Market by Application
10.4.6.2 Saudi Arabia Antisense And RNAi Therapeutics Market
10.4.6.2.1 Saudi Arabia Antisense And RNAi Therapeutics Market by Type
10.4.6.2.2 Saudi Arabia Antisense And RNAi Therapeutics Market by Route of Administration
10.4.6.2.3 Saudi Arabia Antisense And RNAi Therapeutics Market by Application
10.4.6.3 U.A.E Antisense And RNAi Therapeutics Market
10.4.6.3.1 U.A.E Antisense And RNAi Therapeutics Market by Type
10.4.6.3.2 U.A.E Antisense And RNAi Therapeutics Market by Route of Administration
10.4.6.3.3 U.A.E Antisense And RNAi Therapeutics Market by Application
10.4.6.4 Rest of Middle East and Africa Antisense And RNAi Therapeutics Market
10.4.6.4.1 Rest of Middle East and Africa Antisense And RNAi Therapeutics Market by Type
10.4.6.4.2 Rest of Middle East and Africa Antisense And RNAi Therapeutics Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Antisense And RNAi Therapeutics Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Antisense And RNAi Therapeutics Market Overview
10.5.2 South and Central America Antisense And RNAi Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Type
10.5.4 South and Central America Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Application
10.5.6 South and Central America Antisense And RNAi Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Antisense And RNAi Therapeutics Market
10.5.6.1.1 Brazil Antisense And RNAi Therapeutics Market by Type
10.5.6.1.2 Brazil Antisense And RNAi Therapeutics Market by Route of Administration
10.5.6.1.3 Brazil Antisense And RNAi Therapeutics Market by Application
10.5.6.2 Argentina Antisense And RNAi Therapeutics Market
10.5.6.2.1 Argentina Antisense And RNAi Therapeutics Market by Type
10.5.6.2.2 Argentina Antisense And RNAi Therapeutics Market by Route of Administration
10.5.6.2.3 Argentina Antisense And RNAi Therapeutics Market by Application
10.5.6.3 Rest of South and Central America Antisense And RNAi Therapeutics Market
10.5.6.3.1 Rest of South and Central America Antisense And RNAi Therapeutics Market by Type
10.5.6.3.2 Rest of South and Central America Antisense And RNAi Therapeutics Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Antisense And RNAi Therapeutics Market by Application

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. ANTISENSE AND RNAI THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. ALNYLAM PHARMACEUTICALS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BENITEC BIOPHARMA LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. QUARK PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. IONIS PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASTELLAS PHARMA INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MARINA BIOSCIENCES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANOFI S
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. DICERNA PHARMACEUTICALS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TEKMIRA PHARMACEUTICALS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MERCK
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Alnylam Pharmaceuticals
2. Benitec Biopharma Ltd.
3. Quark Pharmaceuticals
4. Ionis Pharmaceuticals
5. Astellas Pharma Inc
6. Marina Biosciences
7. Sanofi S
8. Dicerna Pharmaceuticals
9. Tekmira Pharmaceuticals
10. Merck
TIPRE00023784
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking